|
Volumn 18, Issue 3, 2002, Pages 147-152
|
Erythropoietic protoporphyria (EPP) at 40. Where are we now?
|
Author keywords
Erythropoietic; Ferrochelatase; Protoporphyria
|
Indexed keywords
ACETYLCYSTEINE;
ANTIHISTAMINIC AGENT;
BETA CAROTENE;
CANTHAXANTHIN;
COMPLEMENTARY DNA;
FERROCHELATASE;
SUNSCREEN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BLOOD TRANSFUSION;
BONE MARROW TRANSPLANTATION;
CLINICAL PRACTICE;
ERYTHROPOIETIC PROTOPORPHYRIA;
HUMAN;
MOLECULAR BIOLOGY;
MOLECULAR GENETICS;
MOUSE;
NONHUMAN;
PATHOGENESIS;
PHOTOTHERAPY;
PRIORITY JOURNAL;
VIRAL GENE THERAPY;
ANIMAL;
ENZYMOLOGY;
GENE THERAPY;
GENETICS;
HEPATOERYTHROPOIETIC PORPHYRIA;
REVIEW;
ANIMAL;
FERROCHELATASE;
GENE THERAPY;
HUMAN;
MICE;
MOLECULAR BIOLOGY;
PORPHYRIA, ERYTHROHEPATIC;
ANIMALS;
HUMANS;
PORPHYRIA, HEPATOERYTHROPOIETIC;
|
EID: 0036592055
PISSN: 09054383
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0781.2002.00708.x Document Type: Article |
Times cited : (17)
|
References (45)
|